about
Usefulness of portal vein pressure for predicting the effects of tolvaptan in cirrhotic patientsThe treatment of vasopressin V2-receptor antagonists in cirrhosis patients with ascites: a meta-analysis of randomized controlled trials.Predictors of refractory ascites development in patients with hepatitis B virus-related cirrhosis hospitalized to control ascitic decompensationClinical Profile and Complications of Paracentesis in Refractory Ascites Patients With CirrhosisAutomated low flow pump system for the treatment of refractory ascites: a single-center experience.Effectiveness of tolvaptan monotherapy and low-dose furosemide/tolvaptan combination therapy for hepatoprotection and diuresis in a rat cirrhotic modelTolvaptan for improvement of hepatic edema: A phase 3, multicenter, randomized, double-blind, placebo-controlled trial.Refractory Ascites: Pathogenesis, Clinical Impact, and Management.
P2860
Q24658600-2683C0EB-A7BE-4E0E-9766-2749B7FAB158Q35657152-5D87A329-CA0E-4539-8878-6DD923768847Q36463876-3346E96F-046A-47BA-A3D0-F2B34DF02223Q37292886-DFC1FD48-FA71-4B50-BFE5-5C61A0445C6DQ40322777-9FCDD9E8-27C7-4FC3-A218-31922937D11BQ41110019-9C4147E8-CDE2-44E8-A888-0E83FD47BD97Q45107672-F2FD9C5C-C9F7-4EFA-8A04-6FB48C8FDF60Q55436802-757177A8-A551-4A28-B5E0-B9DB858F4DAF
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Refractory ascites.
@ast
Refractory ascites.
@en
type
label
Refractory ascites.
@ast
Refractory ascites.
@en
prefLabel
Refractory ascites.
@ast
Refractory ascites.
@en
P2860
P356
P1433
P1476
Refractory ascites.
@en
P2093
Andrés Cárdenas
Vicente Arroyo
P2860
P356
10.1159/000084723
P577
2005-01-01T00:00:00Z